Finch Therapeutics Revenue and Competitors

Claim your profile

Boston, MA USA



Total Funding



Estimated Revenue & Valuation

  • Finch Therapeutics's estimated annual revenue is currently $19.5M per year.(i)
  • Finch Therapeutics received $36.0M in venture funding in March 2018.
  • Finch Therapeutics's estimated revenue per employee is $697,500
  • Finch Therapeutics's total funding is $188.8M.
  • Finch Therapeutics's current valuation is $432.1M. (January 2022)

Employee Data

  • Finch Therapeutics has 28 Employees.(i)
  • Finch Therapeutics grew their employee count by -49% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Finch Therapeutics is unlocking the therapeutic potential of the microbiome through our human-first discovery platform. We use machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus our in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Our team values transparency, integrity, humility, and collaboration, and we intend to have fun while maximizing our ability to make an impact on patients lives.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Finch Therapeutics News

2022-04-17 - Finch Therapeutics to shed 20% of its workforce

The workforce reduction, which will impact 37 employees, follows Finch's recent move to pause its chronic hepatitis B program, the clinical hold...

2022-04-17 - Bear market shows no signs of abating, claiming Finch ...

Finch Therapeutics reported Tuesday morning that it would be laying off 37 staffers, or approximately 20% of its workforce,...

2022-03-30 - Finch Therapeutics Reports Fourth Quarter and Full Year ...

Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class...

2020-09-21 - Microbiome Drug Development Company Finch Therapeutics Raises $90 Million

Clinical-stage microbiome drug development company Finch Therapeutics announced that it has raised a $90 million Series D funding round Clinical-stage microbiome drug development company Finch Therapeutics announced that it has raised a $90 million Series D funding round. New investors in this ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Finch Therapeutics Funding

DateAmountRoundLead InvestorsReference